Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | MLYCD | O95822 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17611087 | 0.79 | RAB9A (0.41) | HTTMLYCDMEN1RAB9AKMT2A | |
| SCHEMBL17611061 | 0.70 | ALDH1A1 (0.46) | HTTMEN1RAB9AKMT2A | |
| SCHEMBL12247426 | 0.70 | HTT (0.58) | HTTMLYCDMEN1RAB9AKMT2A | |
| SCHEMBL17604235 | 0.68 | HTT (0.43) | HTTMLYCDMEN1RAB9AKMT2A | |
| SCHEMBL21879981 | 0.65 | RAB9A (0.46) | HTTMEN1RAB9AKMT2ACYP11B1 | |
| SCHEMBL21879877 | 0.63 | HTT (0.47) | HTTMEN1RAB9AKMT2AMAPK1 | |
| SCHEMBL25327703 | 0.62 | MAPK14 (0.33) | — | |
| SCHEMBL31138709 | 0.60 | OPRK1 (0.37) | MEN1RAB9AKMT2AMAPK1 | |
| SCHEMBL30664848 | 0.60 | ATR (0.38) | HTTMEN1KMT2AMAPK1 | |
| SCHEMBL24559139 | 0.60 | ALDH1A1 (0.39) | HTTMEN1RAB9AKMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024726-A1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE | KINNATE BIOPHARMA INC. (US) | 2025-01-30 | — | — | WO | disclosed |